{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T12:20:48Z","timestamp":1787746848142,"version":"build-2784847793"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.humpath.2026.106237","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T23:22:13Z","timestamp":1787095333000},"page":"106237","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pathologist-recommended molecular testing in endometrial cancer: A single-institution experience highlighting the recognition of POLE-Mutated carcinomas in post-menopausal and advanced stage patients, immunohistochemical pitfalls, and other clinically significant findings"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2686-4857","authenticated-orcid":false,"given":"Anne M.","family":"Mills","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Vidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David K.","family":"Carlson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Crawford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akisha","family":"Glasgow-Austin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0431-503X","authenticated-orcid":false,"given":"Vanessa L.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kari L.","family":"Ring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8521-300X","authenticated-orcid":false,"given":"Eyas","family":"Alzayadneh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7447","key":"10.1016\/j.humpath.2026.106237_bib1","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nature12113","article-title":"Integrated genomic characterization of endometrial carcinoma","volume":"497","author":"Network","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.humpath.2026.106237_bib2","doi-asserted-by":"crossref","DOI":"10.1002\/cncr.30496","article-title":"Confirmation of ProMisE: a simple, genomics-based clinical classifier for endometrial cancer","author":"Talhouk","year":"2017","journal-title":"Cancer"},{"issue":"14","key":"10.1016\/j.humpath.2026.106237_bib3","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1002\/cncr.33516","article-title":"Evaluation of treatment effects in patients with endometrial cancer and POLE mutations: an individual patient data meta-analysis","volume":"127","author":"McAlpine","year":"2021","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.humpath.2026.106237_bib4","article-title":"The significance of international Federation of gynecology and obstetrics grading in microsatellite instability-high and POLE-mutant endometrioid endometrial carcinoma","volume":"36","author":"Kertowidjojo","year":"2023","journal-title":"Mod Pathol Off J U S Can Acad Pathol Inc"},{"issue":"2","key":"10.1016\/j.humpath.2026.106237_bib5","article-title":"Pathogenic POLE-Mutated endometrial carcinomas with a nonultramutated genome","volume":"39","author":"Srikumar","year":"2026","journal-title":"Mod Pathol Off J U S Can Acad Pathol Inc"},{"issue":"3","key":"10.1016\/j.humpath.2026.106237_bib6","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/PAS.0000000000002503","article-title":"A deeper dive into POLE -Mutated endometrial carcinomas : the contributions and consequences of tumor mutational burden","volume":"50","author":"Vemuri","year":"2026","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.humpath.2026.106237_bib7","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1136\/ijgc-2022-004039","article-title":"Refining adjuvant treatment in endometrial cancer based on molecular features: the RAINBO clinical trial program","volume":"33","year":"2023","journal-title":"Int J Gynecol Cancer Off J Int Gynecol Cancer Soc"},{"key":"10.1016\/j.humpath.2026.106237_bib8","doi-asserted-by":"crossref","unstructured":"Berek JS, Matias-Guiu X, Creutzberg C, et al. FIGO staging of endometrial cancer: 2023. Int J Gynaecol Obstet Off Organ Int Fed Gynaecol Obstet. Published online June 20, 2023. doi:10.1002\/ijgo.14923.","DOI":"10.3802\/jgo.2023.34.e85"},{"issue":"1","key":"10.1016\/j.humpath.2026.106237_bib9","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1136\/ijgc-2020-002230","article-title":"ESGO\/ESTRO\/ESP guidelines for the management of patients with endometrial carcinoma","volume":"31","author":"Concin","year":"2021","journal-title":"Int J Gynecol Cancer"},{"issue":"3","key":"10.1016\/j.humpath.2026.106237_bib10","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/PAS.0000000000002165","article-title":"Specific pathology features enrich selection of endometrial carcinomas for POLE testing","volume":"48","author":"Keyhanian","year":"2024","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.humpath.2026.106237_bib11","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/PAS.0000000000001461","article-title":"Endometrial carcinomas with a \u201cserous\u201d component in young women are enriched for DNA mismatch repair deficiency, Lynch syndrome, and POLE exonuclease domain mutations","volume":"44","author":"Conlon","year":"2020","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.humpath.2026.106237_bib12","first-page":"986","article-title":"Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): joint recommendations of clinical genome resource (ClinGen), cancer genomics consortium (CGC), and variant interpretation for cancer consortium (VICC)","volume":"24","author":"Horak","year":"2022","journal-title":"Genet Med Off J Am Coll Med Genet"},{"issue":"3","key":"10.1016\/j.humpath.2026.106237_bib13","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/path.5373","article-title":"Clinicopathological and molecular characterisation of \u2018multiple-classifier\u2019 endometrial carcinomas","volume":"250","author":"Le\u00f3n-Castillo","year":"2020","journal-title":"J Pathol"},{"issue":"2","key":"10.1016\/j.humpath.2026.106237_bib14","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1136\/ijgc-2023-004864","article-title":"Clinicopathological characteristics of multiple-classifier endometrial cancers: a cohort study and systematic review","volume":"34","author":"De Vitis","year":"2024","journal-title":"Int J Gynecol Cancer Off J Int Gynecol Cancer Soc"},{"issue":"4","key":"10.1016\/j.humpath.2026.106237_bib15","first-page":"505","article-title":"Clinicopathological analysis of endometrial carcinomas harboring somatic POLE exonuclease domain mutations","volume":"28","author":"Hussein","year":"2015","journal-title":"Mod Pathol Off J U S Can Acad Pathol Inc"},{"key":"10.1016\/j.humpath.2026.106237_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ygyno.2024.09.008","article-title":"Concurrent POLE hotspot mutations and mismatch repair deficiency\/microsatellite instability in endometrial cancer: a challenge in molecular classification","volume":"191","author":"Moufarrij","year":"2024","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.humpath.2026.106237_bib17","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/path.5375","article-title":"p53 immunohistochemistry is an accurate surrogate for TP53 mutational analysis in endometrial carcinoma biopsies","volume":"250","author":"Singh","year":"2020","journal-title":"J Pathol"},{"issue":"3","key":"10.1016\/j.humpath.2026.106237_bib18","doi-asserted-by":"crossref","first-page":"472","DOI":"10.4161\/cc.9.3.10556","article-title":"Mechanism of p53 stabilization by ATM after DNA damage","volume":"9","author":"Cheng","year":"2010","journal-title":"Cell Cycle"},{"key":"10.1016\/j.humpath.2026.106237_bib19","doi-asserted-by":"crossref","DOI":"10.5402\/2011\/931813","article-title":"The role of p53 and MDM2 in head and neck cancer","volume":"2011","author":"Denaro","year":"2011","journal-title":"ISRN Otolaryngol"},{"issue":"3","key":"10.1016\/j.humpath.2026.106237_bib20","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s10522-025-10249-4","article-title":"ATM and p53 in aging and cancer: a double-edged sword in genomic integrity","volume":"26","author":"Pandey","year":"2025","journal-title":"Biogerontology"},{"issue":"1","key":"10.1016\/j.humpath.2026.106237_bib21","doi-asserted-by":"crossref","first-page":"S123","DOI":"10.1097\/PGP.0000000000000488","article-title":"Interpretation of P53 immunohistochemistry in endometrial carcinomas: toward increased reproducibility","volume":"38","author":"K\u00f6bel","year":"2019","journal-title":"Int J Gynecol Pathol"},{"issue":"10","key":"10.1016\/j.humpath.2026.106237_bib22","first-page":"1475","article-title":"p53 immunohistochemistry in endometrial cancer: clinical and molecular correlates in the PORTEC-3 trial","volume":"35","author":"Vermij","year":"2022","journal-title":"Mod Pathol Off J U S Can Acad Pathol Inc"},{"key":"10.1016\/j.humpath.2026.106237_bib23","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.ygyno.2015.01.541","article-title":"Detection of DNA mismatch repair (MMR) deficiencies by immunohistochemistry can effectively diagnose the microsatellite instability (MSI) phenotype in endometrial carcinomas","volume":"137","author":"McConechy","year":"2015","journal-title":"Gynecol Oncol"},{"issue":"8","key":"10.1016\/j.humpath.2026.106237_bib24","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1097\/PAS.0000000000002064","volume":"47","author":"Makia","year":"2023","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.humpath.2026.106237_bib25","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1053\/j.gastro.2014.01.041","article-title":"Differentiating lynch-like from Lynch syndrome","volume":"146","author":"Carethers","year":"2014","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.humpath.2026.106237_bib26","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1158\/1940-6207.CAPR-11-0288","article-title":"Identification of cancer patients with Lynch syndrome: clinically significant discordances and problems in tissue-based mismatch repair testing","volume":"5","author":"Bartley","year":"2012","journal-title":"Cancer Prev Res Phila Pa"},{"key":"10.1016\/j.humpath.2026.106237_bib27","series-title":"Female genital tumours","year":"2020"},{"issue":"15","key":"10.1016\/j.humpath.2026.106237_bib28","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1002\/cncr.34328","article-title":"Molecular classification in endometrial cancer: opportunities for precision oncology in a changing landscape","volume":"128","author":"Jamieson","year":"2022","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.humpath.2026.106237_bib29","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s44276-025-00145-2","article-title":"Next-generation sequencing outperforms proactive molecular risk classifier for endometrial cancer (ProMisE) in endometrial cancer molecular classification","volume":"3","author":"Yoshimura","year":"2025","journal-title":"BJC Rep"},{"key":"10.1016\/j.humpath.2026.106237_bib30","article-title":"Mesonephric and mesonephric-like carcinomas of the female genital tract: molecular characterization including cases with mixed histology and matched metastases","volume":"26","author":"da Silva","year":"2021","journal-title":"Mod Pathol"},{"issue":"4","key":"10.1016\/j.humpath.2026.106237_bib31","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/PAS.0000000000001401","article-title":"Mesonephric-like carcinoma of the endometrium: a subset of endometrial carcinoma with an aggressive behavior","volume":"44","author":"Euscher","year":"2020","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.humpath.2026.106237_bib32","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/s00432-019-03123-7","article-title":"Mesonephric-like adenocarcinomas of the uterine corpus: report of a case series and review of the literature indicating poor prognosis for this subtype of endometrial adenocarcinoma","volume":"146","author":"Horn","year":"2020","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"10.1016\/j.humpath.2026.106237_bib33","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/PGP.0000000000001150","article-title":"Mesonephric-like adenocarcinoma (MLA) diagnostic criteria and controversies: perspectives and guidance from pathologists in the MLA consortium","volume":"45","author":"Mills","year":"2026","journal-title":"Int J Gynecol Pathol Off J Int Soc Gynecol Pathol"},{"issue":"1","key":"10.1016\/j.humpath.2026.106237_bib34","first-page":"68","article-title":"Pilomatrix-like high-grade endometrioid carcinoma is a morphologically and immunophenotypically distinct entity and may show mismatch repair deficiency","volume":"42","author":"Arciuolo","year":"2023","journal-title":"Mod Pathol Off J U S Can Acad Pathol Inc"},{"issue":"8","key":"10.1016\/j.humpath.2026.106237_bib35","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1097\/PAS.0000000000002402","article-title":"Pilomatrix-like high-grade endometrial carcinoma: an underdiagnosed entity with aggressive clinicopathologic features","volume":"49","author":"Zhou","year":"2025","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2026.106237_bib36","article-title":"An expanded series of pilomatrix-like high-grade endometrioid carcinoma (PiMHEC), including both MMR deficient and MMR proficient cases","author":"Xu","year":"2023","journal-title":"Int J Gynecol Pathol Off J Int Soc Gynecol Pathol"},{"key":"10.1016\/j.humpath.2026.106237_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.humpath.2025.106031","article-title":"Endometrial gastric (gastrointestinal)-type mucinous adenocarcinoma: diagnostic criteria, differential diagnosis, and molecular insights","volume":"170","author":"Nam","year":"2026","journal-title":"Hum Pathol"},{"issue":"2","key":"10.1016\/j.humpath.2026.106237_bib38","first-page":"107","article-title":"Endometrial carcinoma of Gastrointestinal-type (EMCG): incidence, molecular features, and distinction from other endometrial cancers with gastrointestinal marker immunoexpression","volume":"45","author":"Alzayadneh","year":"2026","journal-title":"Mod Pathol Off J U S Can Acad Pathol Inc"},{"issue":"6","key":"10.1016\/j.humpath.2026.106237_bib39","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1097\/PAS.0000000000002382","article-title":"Primary endometrial gastric (Gastrointestinal)-type mucinous adenocarcinoma: a detailed clinicopathologic and molecular analysis of 27 cases","volume":"49","author":"Kaur","year":"2025","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"10.1016\/j.humpath.2026.106237_bib40","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1038\/s41416-023-02141-0","article-title":"Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistry","volume":"128","author":"Vermij","year":"2023","journal-title":"Br J Cancer"},{"issue":"4","key":"10.1016\/j.humpath.2026.106237_bib41","article-title":"Grade and estrogen receptor expression identify a subset of no specific molecular profile endometrial carcinomas at a very low risk of disease-specific death","volume":"36","author":"Jamieson","year":"2023","journal-title":"Mod Pathol Off J U S Can Acad Pathol Inc"},{"key":"10.1016\/j.humpath.2026.106237_bib42","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ygyno.2024.01.044","article-title":"Evaluation of prognostic potential of \u03b2-catenin and L1CAM expression according to endometrial cancer risk group","volume":"184","author":"Yoon","year":"2024","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.humpath.2026.106237_bib43","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ygyno.2023.10.025","article-title":"Aberrant nuclear \u03b2-catenin distribution does not prognosticate recurrences of endometrioid endometrial cancers - a retrospective single-institutional study","volume":"179","author":"Beshar","year":"2023","journal-title":"Gynecol Oncol"},{"issue":"5","key":"10.1016\/j.humpath.2026.106237_bib44","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov"},{"issue":"11","key":"10.1016\/j.humpath.2026.106237_bib45","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1001\/jamaoncol.2016.1820","article-title":"Uterine cancer after risk-reducing salpingo-oophorectomy without hysterectomy in women with BRCA mutations","volume":"2","author":"Shu","year":"2016","journal-title":"JAMA Oncol"},{"issue":"2","key":"10.1016\/j.humpath.2026.106237_bib46","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/cncr.27720","article-title":"BRCA1, TP53, and CHEK2 germline mutations in uterine serous carcinoma","volume":"119","author":"Pennington","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2026.106237_bib47","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ejca.2016.11.028","article-title":"Linking uterine serous carcinoma to BRCA1\/2-associated cancer syndrome: a meta-analysis and case report","volume":"72","author":"de Jonge","year":"2017","journal-title":"Eur J Cancer Oxf Engl"},{"issue":"4","key":"10.1016\/j.humpath.2026.106237_bib48","first-page":"515","article-title":"Uterine PEComas: correlation between melanocytic marker expression and TSC alterations\/TFE3 fusions","volume":"35","author":"Bennett","year":"2022","journal-title":"Mod Pathol Off J U S Can Acad Pathol Inc"},{"issue":"7","key":"10.1016\/j.humpath.2026.106237_bib49","first-page":"977","article-title":"Characteristics of mismatch repair deficiency in sarcomas","volume":"32","author":"Doyle","year":"2019","journal-title":"Mod Pathol Off J U S Can Acad Pathol Inc"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817726002066?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817726002066?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T11:42:38Z","timestamp":1787744558000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817726002066"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":49,"alternative-id":["S0046817726002066"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2026.106237","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pathologist-recommended molecular testing in endometrial cancer: A single-institution experience highlighting the recognition of POLE-Mutated carcinomas in post-menopausal and advanced stage patients, immunohistochemical pitfalls, and other clinically significant findings","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2026.106237","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106237"}}